摘要
目的:观察咪唑斯汀治疗慢性荨麻疹的临床疗效的安全性。方法:采用多中心、开放、临床研究方法,人选病例每日日服一片咪唑斯汀(每片10mg),疗程为14d。结果:共治疗858例,其中男400例,女458例。用药后第7 d的有效率为 85.1%,第 14 d的有效率为 95.0%。药物不良反应较轻,发生率为4.1%。结论:咪唑斯汀是一种治疗慢性荨麻疹安全有效的药物。
To observe the clinical efficacy and safety of mizolastine in the treatment ofchronic urticaria. Methods: A multicenter, open, clinical study was conducted. The patients withchronic urticaria applied orally a tablet of mizolastine (20 mg per tablet) daily for 14 days. Results: Atotal of 858 patients with chronic urticaria were treated, of which 400 cases were male, 458 were fe-male. The effective rate was 85. 1 % by one week treatment, and 95 .0% by two weeks treatment. Theadverse reaction was mild, the occurrence rate was 4. 1 %. Conclusion: Mizolastine is a sdfe and effec-tive agent in the treatment of chronic urticaria.
出处
《岭南皮肤性病科杂志》
2002年第1期13-15,共3页
Southern China Journal of Dermato-Venereology